Nick Cunniffe

403 total citations
14 papers, 167 citations indexed

About

Nick Cunniffe is a scholar working on Pathology and Forensic Medicine, Molecular Biology and Developmental Neuroscience. According to data from OpenAlex, Nick Cunniffe has authored 14 papers receiving a total of 167 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pathology and Forensic Medicine, 7 papers in Molecular Biology and 3 papers in Developmental Neuroscience. Recurrent topics in Nick Cunniffe's work include Multiple Sclerosis Research Studies (10 papers), Retinoids in leukemia and cellular processes (4 papers) and Retinal Development and Disorders (3 papers). Nick Cunniffe is often cited by papers focused on Multiple Sclerosis Research Studies (10 papers), Retinoids in leukemia and cellular processes (4 papers) and Retinal Development and Disorders (3 papers). Nick Cunniffe collaborates with scholars based in United Kingdom, Australia and Portugal. Nick Cunniffe's co-authors include Alasdair Coles, J William L Brown, Robin J.M. Franklin, Christopher E McMurran, Declan Chard, Joanne Jones, Andrew W. Michell, Lorna B. Jarvis, Daniel B. Rainbow and Edward Needham and has published in prestigious journals such as Brain, Frontiers in Immunology and Journal of Neurology.

In The Last Decade

Nick Cunniffe

9 papers receiving 165 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nick Cunniffe United Kingdom	5	76	60	59	58	22	14	167
Jan Winchenbach Germany	3	36 0.5×	64 1.1×	68 1.2×	57 1.0×	34 1.5×	3	172
Aletta M.R. van den Bosch Netherlands	6	43 0.6×	50 0.8×	69 1.2×	50 0.9×	29 1.3×	9	179
Jessica L. Zambonin Canada	4	98 1.3×	76 1.3×	80 1.4×	117 2.0×	14 0.6×	7	229
Lena Spieth Germany	7	33 0.4×	56 0.9×	73 1.2×	99 1.7×	46 2.1×	9	247
Hannes Kaddatz Germany	7	49 0.6×	55 0.9×	121 2.1×	66 1.1×	59 2.7×	10	229
Manuel Marzin Netherlands	6	38 0.5×	21 0.3×	93 1.6×	118 2.0×	38 1.7×	8	266
Minou Djannatian Germany	5	27 0.4×	87 1.4×	104 1.8×	93 1.6×	39 1.8×	7	238
Prech Uapinyoying United States	8	18 0.2×	40 0.7×	46 0.8×	132 2.3×	35 1.6×	12	248
Florian Pernin Canada	9	24 0.3×	76 1.3×	80 1.4×	88 1.5×	37 1.7×	11	183
Christopher Halfpenny United Kingdom	7	62 0.8×	54 0.9×	31 0.5×	48 0.8×	13 0.6×	10	172

Countries citing papers authored by Nick Cunniffe

Since Specialization

Citations

This map shows the geographic impact of Nick Cunniffe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nick Cunniffe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nick Cunniffe more than expected).

Fields of papers citing papers by Nick Cunniffe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nick Cunniffe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nick Cunniffe. The network helps show where Nick Cunniffe may publish in the future.

Co-authorship network of co-authors of Nick Cunniffe

This figure shows the co-authorship network connecting the top 25 collaborators of Nick Cunniffe. A scholar is included among the top collaborators of Nick Cunniffe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nick Cunniffe. Nick Cunniffe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Chen, Benson, et al.. (2025). Myelination of the retinal nerve fibre layer: A case report. Multiple Sclerosis Journal. 32(3). 347–350.

McMurran, Christopher E, Jens Kühle, Alasdair Coles, et al.. (2025). Serum neurofilament light chain levels suggest neuroprotection following bexarotene-induced remyelination in people with relapsing remitting multiple sclerosis. Multiple Sclerosis and Related Disorders. 103. 106655–106655.

McMurran, Christopher E, et al.. (2025). Ageing and remyelination failure in people with multiple sclerosis. Brain. 149(1). 48–58.

McMurran, Christopher E, Benson Chen, Wendi Qian, et al.. (2025). The Cambridge Centre for Myelin Repair trial Two (CCMR Two): a trial protocol for a phase 2a, randomised, double-blind, placebo-controlled clinical trial of the ability of the combination of metformin and clemastine to promote remyelination in people with relapsing-remitting multiple sclerosis already on disease-modifying therapy. Trials. 26(1). 562–562.

McMurran, Christopher E, Ermelinda De Meo, Nick Cunniffe, et al.. (2024). Exploratory analysis of biological age measures in a remyelination clinical trial. Brain Communications. 7(1). fcaf032–fcaf032. 3 indexed citations

Chen, Benson, et al.. (2024). Visual outcome measures in clinical trials of remyelinating drugs. BMJ Neurology Open. 6(1). e000560–e000560. 4 indexed citations

Cunniffe, Nick, et al.. (2024). Sensory neuropathy as a manifestation of multiple acyl-coenzyme A dehydrogenase deficiency. BMJ Case Reports. 17(3). e259192–e259192. 2 indexed citations

McMurran, Christopher E, et al.. (2024). Bexarotene leads to durable improvements in visual evoked potential latency: A follow-up study of the Cambridge Centre for Myelin Repair One trial. Multiple Sclerosis Journal. 30(8). 1066–1071. 2 indexed citations

Brown, J William L, Ferrán Prados, Daniel R. Altmann, et al.. (2022). Remyelination varies between and within lesions in multiple sclerosis following bexarotene. Annals of Clinical and Translational Neurology. 9(10). 1626–1642. 14 indexed citations

10.

Hill, Myfanwy F. E., Nick Cunniffe, & Robin J.M. Franklin. (2022). Seeing is believing: Identifying remyelination in the central nervous system. Current Opinion in Pharmacology. 66. 102269–102269. 4 indexed citations

11.

McMurran, Christopher E, J William L Brown, Andrew W. Michell, et al.. (2022). Remyelination in humans due to a retinoid‐X receptor agonist is age‐dependent. Annals of Clinical and Translational Neurology. 9(7). 1090–1094. 15 indexed citations

12.

Cunniffe, Nick, et al.. (2022). Carpenter's Neurophysiology.

13.

Rainbow, Daniel B., Lorna B. Jarvis, Nick Cunniffe, et al.. (2021). The MS Remyelinating Drug Bexarotene (an RXR Agonist) Promotes Induction of Human Tregs and Suppresses Th17 Differentiation In Vitro. Frontiers in Immunology. 12. 712241–712241. 16 indexed citations

14.

Cunniffe, Nick & Alasdair Coles. (2019). Promoting remyelination in multiple sclerosis. Journal of Neurology. 268(1). 30–44. 107 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact